| Literature DB >> 24228058 |
Yong-Ouk You1, Na-Young Choi, Kang-Ju Kim.
Abstract
In this study, root bark of Ulmus pumila (U. pumila) was extracted with ethanol, and then the antimicrobial effects were tested on clinically isolated 12 MRSA strains and 1 standard MRSA strain. U. pumila showed antibacterial activities against all MRSA strains. Minimum inhibitory concentration (MIC) of U. pumila root bark against all MRSA strains revealed a range from 125 to 250 μ g/mL. These results may provide the scientific basis on which U. pumila root bark has traditionally been used against infectious diseases in Korea. In real-time PCR analysis, the sub-MIC (64-125 μ g/mL) concentrations of U. pumila root bark extract showed the inhibition of the genetic expressions of virulence factors such as mecA, sea, agrA, and sarA in standard MRSA. Phytochemical analyses of U. pumila root bark showed relatively strong presence of phenolics, steroids, and terpenoids. These results suggest that the ethanol extract of U. pumila root bark may have antibacterial activity against MRSA, which may be related to the phytochemicals such as phenolics, steroids, and terpenoids. Further studies are needed to determine the active constituents of U. pumila root bark responsible for such biomolecular activities.Entities:
Year: 2013 PMID: 24228058 PMCID: PMC3817893 DOI: 10.1155/2013/269874
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Bacterial strains used the test of antibacterial activity.
| Strains | Class |
|
| Antibiotic resistance pattern |
|---|---|---|---|---|
|
| MRSA | + | + | AM, OX, CF, E |
| Clinical isolates | ||||
|
| MRSA | + | + | AM, OX |
|
| MRSA | + | + | AM, OX, E |
|
| MRSA | + | + | AM, OX, CF, E |
|
| MRSA | + | + | AM, OX, E |
|
| MRSA | + | + | AM, OX, CF, E |
|
| MRSA | + | + | AM, OX, E |
|
| MRSA | + | + | AM, OX, CF, E |
|
| MRSA | + | + | AM, OX, CF, E |
|
| MRSA | + | + | AM, OX, CF, E |
|
| MRSA | + | − | AM, OX, E |
|
| MRSA | + | + | AM, OX |
|
| MRSA | + | + | AM, OX |
+: positive; −: negative; AM: ampicillin; OX: oxacillin; CF: cephalothin; E: erythromycin.
OMS indicates Staphylococcal strains of Department of Oral and Maxillofacial Surgery, Wonkwang University Hospital.
Nucleotide sequences of primer used for real-time PCR in this study.
| Gene | Gene description | Primer sequences (5′-3′) | |
|---|---|---|---|
|
| Normalizing internal standard | Forward | ACTGGGATAACTTCGGGAAA |
| Reverse | CGTTGCCTTGGTAAGCC | ||
|
| Penicillin binding protein 2′ | Forward | GTTAGATTGGGATCATAGCGTCATT |
| Reverse | TGCCTAATCTCATATGTGTTCCTGTAT | ||
|
| Staphylococcal enterotoxin A | Forward | ATGGTGCTTATTATGGTTATC |
| Reverse | CGTTTCCAAAGGTACTGTATT | ||
|
| Accessory gene regulator A | Forward | TGATAATCCTTATGAGGTGCTT |
| Reverse | CACTGTGACTCGTAACGAAAA | ||
|
| Staphylococcal accessory regulator A | Forward | TGTTATCAATGGTCACTTATGCTG |
| Reverse | TCTTTGTTTTCGCTGATGTATGTC | ||
Antimicrobial activity (mm inhibition zones diameter) of extracts of Ulmus pumila against 12 methicillin-resistant Staphylococcus aureus (MRSA) and 1 standard MRSA.
| Strains | Zone of inhibition (mm) | ||||
|---|---|---|---|---|---|
|
| Ampicillina | Oxacillinb | |||
| 0.25 | 0.5 | 1 | 10 | 1 | |
|
| 10 | 12 | 14 | 10 | ND |
| Clinical isolates | |||||
|
| 11 | 13 | 16 | 12 | 9 |
|
| ND | 9 | 14 | 11 | ND |
|
| 9 | 11 | 15 | 11 | ND |
|
| 10 | 14 | 16 | 11 | ND |
|
| 10 | 12 | 14 | 11 | ND |
|
| 11 | 15 | 17 | 10 | ND |
|
| ND | 10 | 14 | 8 | ND |
|
| 9 | 13 | 15 | 10 | ND |
|
| 9 | 12 | 14 | 10 | ND |
|
| 12 | 15 | 18 | 17 | ND |
|
| 11 | 14 | 17 | 11 | ND |
|
| 13 | 16 | 19 | 11 | ND |
ND: no detected activity at this concentration; C: chloroform extract; B: n-butanol extract; M: methanol extract; A: aqueous extract.
aAmpicillin resistance ≤28 mm.
bOxacillin resistance ≤10 mm.
Minimal inhibitory concentrations (MICs) of the Ulmus pumila, ampicillin, and oxacillin against 12 methicillin-resistant Staphylococcus aureus (MRSA) and 1 standard MRSA.
| Strains | MIC ( | ||
|---|---|---|---|
|
| Ampicillin1 | Oxacillin2 | |
|
| 250 | 32 | 256 |
| Clinical isolates | |||
|
| 250 | 32 | 8 |
|
| 250 | 32 | 4 |
|
| 250 | 64 | 4 |
|
| 250 | 64 | 4 |
|
| 250 | 32 | 4 |
|
| 125 | 64 | 16 |
|
| 250 | 32 | 16 |
|
| 250 | 32 | 8 |
|
| 250 | 64 | 8 |
|
| 125 | 4 | 4 |
|
| 125 | 64 | 16 |
|
| 125 | 64 | 4 |
1Ampicillin resistance is an ampicillin MIC of ≥0.25 μg/mL.
2Oxacillin resistance is an oxacillin MIC of ≥4 μg/mL.
OMS indicates Staphylococcal strains of Department of Oral and Maxillofacial Surgery, Wonkwang University Hospital.
Figure 1Real-time PCR analysis of expression of several virulence factor genes. MRSA ATCC 33591 was cultured and treated with sub-MIC concentrations (32–125 μg/mL) of U. pumila extract, and real-time PCR analysis was then performed as described in the Section 2. mecA, sea, sarA, and agrA expressions were significantly inhibited at concentration higher than 64 μg/mL. Each value is expressed as a mean ± standard deviation. Significance was determined at *P < 0.05 when compared with the control.
Phytochemical analysis of the ethanol extract of Ulmus pumila.
| Plant constituents | Ethanol extract |
|---|---|
| Alkaloids | − |
| Phenolics | +++ |
| Flavonoids | + |
| Glycosides | ++ |
| Peptides | + |
| Steroids, terpenoids | +++ |
| Organic acids | + |
+++: strong; ++: moderate; +: poor; −: absent.